Literature DB >> 21307295

Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses.

Katrina Soderquest1, Thierry Walzer, Biljana Zafirova, Linda S Klavinskis, Bojan Polić, Eric Vivier, Graham M Lord, Alfonso Martín-Fontecha.   

Abstract

It is uncertain whether NK cells modulate T cell memory differentiation. By using a genetic model that allows the selective depletion of NK cells, we show in this study that NK cells shape CD8(+) T cell fate by killing recently activated CD8(+) T cells in an NKG2D- and perforin-dependent manner. In the absence of NK cells, the differentiation of CD8(+) T cells is strongly biased toward a central memory T cell phenotype. Although, on a per-cell basis, memory CD8(+) T cells generated in the presence or the absence of NK cells have similar functional features and recall capabilities, NK cell deletion resulted in a significantly higher number of memory Ag-specific CD8(+) T cells, leading to more effective control of tumors carrying model Ags. The enhanced memory responses induced by the transient deletion of NK cells may provide a rational basis for the design of new vaccination strategies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21307295     DOI: 10.4049/jimmunol.1004122

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  65 in total

1.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.

Authors:  Philipp A Lang; Karl S Lang; Haifeng C Xu; Melanie Grusdat; Ian A Parish; Mike Recher; Alisha R Elford; Salim Dhanji; Namir Shaabani; Charles W Tran; Dilan Dissanayake; Ramtin Rahbar; Magar Ghazarian; Anne Brüstle; Jason Fine; Peter Chen; Casey T Weaver; Christoph Klose; Andreas Diefenbach; Dieter Häussinger; James R Carlyle; Susan M Kaech; Tak W Mak; Pamela S Ohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

2.  Yet another role for natural killer cells: cytotoxicity in immune regulation and viral persistence.

Authors:  Christine A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-31       Impact factor: 11.205

Review 3.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

Review 4.  Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy.

Authors:  Kushal Prajapati; Cynthia Perez; Lourdes Beatriz Plaza Rojas; Brianna Burke; Jose A Guevara-Patino
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

Review 5.  Regulation of antiviral T cell responses by type I interferons.

Authors:  Josh Crouse; Ulrich Kalinke; Annette Oxenius
Journal:  Nat Rev Immunol       Date:  2015-03-20       Impact factor: 53.106

6.  Uncompromised NK cell activation is essential for virus-specific CTL activity during acute influenza virus infection.

Authors:  Yuan Liu; Jian Zheng; Yinping Liu; Liyan Wen; Lei Huang; Zheng Xiang; Kwok-Tai Lam; Aizhen Lv; Huawei Mao; Yu-Lung Lau; Wenwei Tu
Journal:  Cell Mol Immunol       Date:  2017-04-17       Impact factor: 11.530

Review 7.  Rapid innate control of antigen abrogates adaptive immunity.

Authors:  Thomas P I Pembroke; Awen M Gallimore; Andrew Godkin
Journal:  Immunology       Date:  2013-04       Impact factor: 7.397

8.  Immunotherapeutic synergy between anti-CD137 mAb and intratumoral administration of a cytopathic Semliki Forest virus encoding IL-12.

Authors:  José I Quetglas; Juan Dubrot; Jaione Bezunartea; Miguel F Sanmamed; Sandra Hervas-Stubbs; Cristian Smerdou; Ignacio Melero
Journal:  Mol Ther       Date:  2012-06-26       Impact factor: 11.454

9.  The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection.

Authors:  Kevin D Cook; Jason K Whitmire
Journal:  J Immunol       Date:  2012-12-12       Impact factor: 5.422

10.  Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

Authors:  Sam C Nalle; H Aimee Kwak; Karen L Edelblum; Nora E Joseph; Gurminder Singh; Galina F Khramtsova; Eric D Mortenson; Peter A Savage; Jerrold R Turner
Journal:  Sci Transl Med       Date:  2014-07-02       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.